Reducing socioeconomic disparities in tobacco dependence treatment outcomes

减少烟草依赖治疗结果的社会经济差异

基本信息

  • 批准号:
    8575111
  • 负责人:
  • 金额:
    $ 31.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-12 至 2017-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tobacco use is a leading contributor to racial and socioeconomic health disparities in the US primarily due to an unequal burden of tobacco-related disease from a disproportionate share of smokers in lower socioeconomic (SES) groups in which minorities, particularly African Americans, are disproportionately represented.1-5 Although deemed effective for all smokers,6 the standard cognitive-behavioral treatment for tobacco dependence is significantly less effective for lower SES smokers.7-15 Tobacco dependence treatment, however, has the potential to reduce racial and socioeconomic disparities in achieving long-term abstinence by proactively providing our most at-risk smokers with the specific treatment components they need to achieve abstinence through the existing extensive treatment delivery system.16, 17 Our preliminary studies indicate that in addition to several socio-cultural barriers to engaging in treatment,18 there are several key factors associated with socioeconomic disparities in relapse rates and thus treatment outcomes. These factors include: stress, negative affect, smoking in response to negative affect, delay discounting, locus of control, impulsiveness, exposure to smokers in the environment, and treatment utilization (see Table 1).19, 20 Based on this and other evidence, our overall goal is to revise the standard treatment with specific, evidence-based, cognitive-behavioral strategies to address these key factors as well as target and tailor the approach to more fully meet the needs of lower SES and minority smokers, thereby reducing treatment outcome disparities. We expect: 1) The revised treatment (RT) to reduce socioeconomic disparities in treatment outcomes, and 2) Participants treated with the RT to demonstrate more improvement on each of the key factors associated with disparities than those treated with standard treatment (ST). The specific aims include: 1) Complete a revised draft of a widely utilized standard treatment manual that addresses each of the key factors with treatment components. This aim is partially accomplished (see Appendix for preliminary draft). 2) Using the PEN-3 Model,21-23 target and tailor the daft RT to more fully represent the experiences of smokers who are of lower SES and /or of minority status, particularly African American smokers. 3) Pilot test the targeted/tailored draft RT with three treatment groups (n=5-10 per group) to assess understandability and acceptability and to ensure that it can be delivered in the same timeframe as the ST. 4) Compare the effects of SES on treatment outcomes with socioeconomically and racially diverse participants treated with ST (n=110) and RT (n=110) in a randomized treatment design. 5) Compare the effects of treatment condition on each of the key factors. This innovative approach refines, improves upon, and applies theoretically derived and empirically supported concepts and strategies. If effective at reducing treatment outcome disparities, the manual-driven RT will be easily disseminable as a "new" standard, having a sustained and powerful impact on the field and contributing to a reduction in the magnitude of the present tobacco-related racial and socioeconomic health disparities.
说明(申请人提供):烟草使用是美国种族和社会经济健康差距的主要因素,主要是由于较低社会经济(SES)群体中吸烟者所占比例不成比例造成的与烟草相关的疾病负担不成比例。1-5尽管认为对所有吸烟者有效,6烟草依赖的标准认知行为疗法对较低的SES吸烟者有效。7-15然而,烟草依赖治疗,16、17我们的初步研究表明,除了在进行治疗方面存在若干社会文化障碍外,18在复发率和治疗结果方面存在若干与社会经济差异有关的关键因素。这些因素包括:压力,负面情绪,吸烟对负面情绪的反应,延迟折扣,控制点,冲动,暴露在环境中的吸烟者,以及治疗利用(见表1)。19,20基于这一证据和其他证据,我们的总体目标是 用具体的、以证据为基础的认知-行为策略修订标准治疗,以解决这些关键因素,并针对和定制方法,以更充分地满足较低SES和少数吸烟者的需求,从而减少治疗结果差异。我们期望:1)修订的治疗(RT)将减少治疗结果中的社会经济差异,2)接受RT治疗的参与者在与差异相关的每个关键因素上比标准治疗(ST)治疗的参与者表现出更多的改善。具体目标包括:1)完成一份广泛使用的标准治疗手册的修订草案,该手册涉及治疗组件的每一个关键因素。这一目标已部分实现(初稿见附录)。2)使用PEN-3模型,21-23目标和定制愚蠢的RT,以更全面地代表较低SES和/或少数族裔地位的吸烟者,特别是非裔美国吸烟者的经历。3)与三个处理组(每组n=5-10)试行有针对性的/量身定制的RT草案,以评估可理解性和可接受性,并确保其能够在与ST相同的时间框架内交付。4)在随机试验设计中,比较社会经济和种族不同的参与者接受ST(n=110)和RT(n=110)治疗的SES对治疗结果的影响。5)比较治疗条件对各关键因素的影响。这一创新方法完善、改进并应用了理论推导和经验支持的概念和策略。如果在减少治疗结果差异方面有效,人工驱动的RT将很容易作为一种“新”标准传播,对该领域产生持续和强大的影响,并有助于减少目前与烟草有关的种族和社会经济健康差异的严重程度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christine Elizabeth Sheffer其他文献

Christine Elizabeth Sheffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christine Elizabeth Sheffer', 18)}}的其他基金

Competency-based training to advance clinical proficiencies and reduce disparities in the treatment of tobacco dependence
基于能力的培训,以提高临床熟练程度并减少烟草依赖治疗方面的差异
  • 批准号:
    10018839
  • 财政年份:
    2019
  • 资助金额:
    $ 31.88万
  • 项目类别:
Competency-based training to advance clinical proficiencies and reduce disparities in the treatment of tobacco dependence
基于能力的培训,以提高临床熟练程度并减少烟草依赖治疗方面的差异
  • 批准号:
    9792039
  • 财政年份:
    2019
  • 资助金额:
    $ 31.88万
  • 项目类别:
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
利用 rTMS 加强复发预防:戒烟剂量反应参数
  • 批准号:
    9927606
  • 财政年份:
    2018
  • 资助金额:
    $ 31.88万
  • 项目类别:
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
利用 rTMS 加强复发预防:戒烟剂量反应参数
  • 批准号:
    10405126
  • 财政年份:
    2018
  • 资助金额:
    $ 31.88万
  • 项目类别:
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
利用 rTMS 加强复发预防:戒烟剂量反应参数
  • 批准号:
    10163136
  • 财政年份:
    2018
  • 资助金额:
    $ 31.88万
  • 项目类别:
Research Education Curriculum and Training (REACT) Program
研究教育课程和培训(REACT)计划
  • 批准号:
    8850213
  • 财政年份:
    2014
  • 资助金额:
    $ 31.88万
  • 项目类别:
The TREND Partnership Administrative Core
TREND 合作伙伴行政核心
  • 批准号:
    8850211
  • 财政年份:
    2014
  • 资助金额:
    $ 31.88万
  • 项目类别:
Reducing socioeconomic disparities in tobacco dependence treatment outcomes
减少烟草依赖治疗结果的社会经济差异
  • 批准号:
    8509786
  • 财政年份:
    2012
  • 资助金额:
    $ 31.88万
  • 项目类别:
Reducing socioeconomic disparities in tobacco dependence treatment outcomes
减少烟草依赖治疗结果的社会经济差异
  • 批准号:
    8607478
  • 财政年份:
    2012
  • 资助金额:
    $ 31.88万
  • 项目类别:
Reducing socioeconomic disparities in tobacco dependence treatment outcomes
减少烟草依赖治疗结果的社会经济差异
  • 批准号:
    8795109
  • 财政年份:
    2012
  • 资助金额:
    $ 31.88万
  • 项目类别:

相似海外基金

Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome
行政补充性别肯定雌激素治疗和乳腺癌治疗结果
  • 批准号:
    10783533
  • 财政年份:
    2023
  • 资助金额:
    $ 31.88万
  • 项目类别:
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
肠道微生物组作为淋巴瘤治疗结果和全身免疫调节因子的前瞻性评估
  • 批准号:
    10419202
  • 财政年份:
    2022
  • 资助金额:
    $ 31.88万
  • 项目类别:
Predictors of Treatment Outcome in a Women's Residential Addiction Treatment Program: The Role of Co-morbid Mental Health Symptoms
女性住院成瘾治疗计划中治疗结果的预测因素:共病心理健康症状的作用
  • 批准号:
    490914
  • 财政年份:
    2022
  • 资助金额:
    $ 31.88万
  • 项目类别:
    Studentship Programs
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
神经源性血浆外泌体 MicroRNA 作为青少年自杀和治疗结果的有前景的新型生物标志物
  • 批准号:
    10684830
  • 财政年份:
    2022
  • 资助金额:
    $ 31.88万
  • 项目类别:
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
肠道微生物组作为淋巴瘤治疗结果和全身免疫调节因子的前瞻性评估
  • 批准号:
    10579302
  • 财政年份:
    2022
  • 资助金额:
    $ 31.88万
  • 项目类别:
Development of preoperative rehabilitation and nutritional support program for improving treatment outcome of elderly gastric cancer patients
制定术前康复和营养支持方案以改善老年胃癌患者的治疗效果
  • 批准号:
    21K11311
  • 财政年份:
    2021
  • 资助金额:
    $ 31.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Aberrant Cdk5 imaging agent for early detection ofAlzheimer's disease pathology and treatment outcome measurement
开发异常 Cdk5 显像剂,用于早期检测阿尔茨海默病病理学和治疗结果测量
  • 批准号:
    10255458
  • 财政年份:
    2021
  • 资助金额:
    $ 31.88万
  • 项目类别:
Gender-affirming estrogen therapy and breast cancer treatment outcome
性别肯定雌激素治疗和乳腺癌治疗结果
  • 批准号:
    10543116
  • 财政年份:
    2021
  • 资助金额:
    $ 31.88万
  • 项目类别:
Identifying Imaging Biomarkers of Deep Brain Stimulation Treatment Outcome in Patients with Movement Disorders
识别运动障碍患者深部脑刺激治疗结果的影像生物标志物
  • 批准号:
    2600608
  • 财政年份:
    2021
  • 资助金额:
    $ 31.88万
  • 项目类别:
    Studentship
Gender-affirming estrogen therapy and breast cancer treatment outcome
性别肯定雌激素治疗和乳腺癌治疗结果
  • 批准号:
    10350731
  • 财政年份:
    2021
  • 资助金额:
    $ 31.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了